SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001306923-20-000004
Filing Date
2020-02-14
Accepted
2020-02-14 13:16:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 Aimmune_13G.txt SC 13G 10409
2 Aimmune_13G.pdf SC 13G 93316
  Complete submission text file 0001306923-20-000004.txt   140763
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88972 | Film No.: 20617316
SIC: 2834 Pharmaceutical Preparations